Worldwide Utilization of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?

被引：0
|
作者：
Alfaifi, S. [1 ,2 ]
Louie, A. V. [3 ]
Siva, S. [4 ]
Guckenberger, M. [5 ]
Videtic, G. M. [6 ]
Higgins, K. [7 ]
Alshafa, F. [2 ]
AlGhamdi, H. [2 ]
Gillespie, E. F. [8 ]
Stephans, K. L. [6 ]
Mula-Hussain, L. [9 ]
Harrow, S. [10 ]
Palma, D. A. [11 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] King Faisal Med City, Abha, Saudi Arabia
[3] Sunnybrook Hlth Sci Ctr Univ, Toronto, ON, Canada
[4] PeterMacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Univ Hosp Zurich, Zurich, Switzerland
[6] Cleveland Clin, Dept Radit Oncol, Cleveland, OH USA
[7] City Of Hope Atlanta, Newnan, GA USA
[8] Univ Washington, Sch Med, Seattle, WA 98104 USA
[9] Dalhousie Univ, Halifax, NS, Canada
[10] Edinburgh Canc Ctr, Edinburgh, Midlothian, Scotland
[11] London Hlth Sci Ctr, London, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2001
引用
收藏
页码：E1 / E2
页数：2
相关论文
共 50 条
  • [31] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [32] Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Marar, M.
    Bryant, A. K.
    Nalawade, V.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    Chin, A. L.
    Murphy, J. D.
    Vitzthum, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E447 - E447
  • [33] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [34] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [35] Stereotactic body radiotherapy for early stage non-small cell lung cancer
    Lagerwaard, F.
    LUNG CANCER, 2012, 77 : S9 - S10
  • [36] Inoperable Early-Stage Non-Small-Cell Lung Cancer: Stereotactic Ablative Radiotherapy and Rationale for Systemic Therapy
    Daly, Megan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 539 - +
  • [37] Significance of Stereotactic Body Radiotherapy in Elderly Patients with Early-Stage Non-Small Cell Lung Cancer
    Maebayashi, T.
    Ishibashi, N.
    Aizawa, T.
    Sakaguchi, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E477 - E477
  • [38] Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer
    Hiley, Crispin
    Salem, Ahmed
    Batchelor, Tim
    McDonald, Fiona
    Evison, Matthew
    THORAX, 2020, 75 (03) : 198 - 199
  • [39] A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
    Tonneau, Marion
    Richard, Corentin
    Routy, Bertrand
    Campeau, Marie-Pierre
    Vu, Toni
    Filion, Edith
    Roberge, David
    Mathieu, Dominique
    Doucet, Robert
    Beliveau-Nadeau, Dominic
    Bahig, Houda
    RADIOTHERAPY AND ONCOLOGY, 2023, 185
  • [40] Salvage guideline for local-regional failure after stereotactic ablative radiotherapy for early-stage non-small cell lung cancer.
    Brooks, Eric
    Sun, Bing
    Zhao, Lina
    Komaki, Ritsuko
    Liao, Zhongxing X.
    Jeter, Melenda
    O'Reilly, Michael
    Welsh, James William
    Gomez, Daniel Richard
    Nguyen, Quynh
    Antonoff, Mara
    Hahn, Stephen M.
    Heyrnach, John
    Rice, David C.
    Chang, Joe Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345